Introducing Prof Timothy Cloughesy, Professor of Neurology at the David Geffen School of Medicine at University of California, Los Angeles. Dr. Cloughesy’s research includes therapeutic, imaging, translational and basic investigations, and is the lead investigator of the global GBM AGILE clinical trial.
Prof Cloughesy’s focus involves novel clinical trial design, incorporation of biomarkers and development of new biomarkers in brain cancer.
